https://m2.mtmt.hu/ eng 2026-10-25 08:59 JournalArticle 36932110 ADMIN_APPROVED true 0 false 2026-06-24T09:38:21.434+0000 2026-06-24T09:36:54.443+0000 2026-02-09T09:35:52.128+0000 true 10099601 Cseresnyés Dorottya /api/admin/10099601 Admin Dorottya Cseresnyés (KIADÓK admin 3) true 2026-06-24T09:36:44.740+0000 2026-06-24T09:36:44.740+0000 2026-06-24T09:36:54.708+0000 true 10062250 Molnár-Taga Márta /api/admin/10062250 Admin Márta Molnár-Taga (SE 4-es admin) true 10062250 true false true 24 24 /api/publicationtype/24 PublicationType Journal Article 1 true 24 JournalArticle true 1134514 Survey paper true 24 24 /api/publicationtype/24 PublicationType Journal Article 1 true 24 JournalArticle /api/subtype/1134514 Összefoglaló cikk SubType Survey paper (Journal Article) 102 true 1134514 true 1 /api/category/1 Category Scientific true 1 Vásárhelyi, Barna Some remarks on the methodology of determining serum creatinine levels, transaminase activity, and albumin levels true true /api/journal/1035675 REVIEWED ORVOSI HETILAP 0030-6002 1788-6120 true true 1035675 false 1035675 true 0030-6002 1788-6120 Journal HUNGARIAN 167 6 211 216 211 6 2026 A modern orvostudomány fejlődése ellenére a klasszikus laboratóriumi paraméterek továbbra is a klinikai döntéshozatal fő pillérei. A közlemény négy, rutinszerűen mért analitra fókuszál: szérum-kreatininszint, májtranszamináz-aktivitások, albuminszint. Ezek 2024-ben a magyarországi laboratóriumi meghatározások több mint 15%-át tették ki. A szérum-kreatininszint mérését a laboratóriumok kétféle módszerrel mérik: Jaffé- vagy enzimatikus módszerrel. Bár mindkettő alkalmas a glomerulusfiltrációs ráta (GFR) becslésére, az eredmények 5–14%-kal eltérhetnek egymástól. A szakmai állásfoglalás szerint mindkét módszer használható, de a leleten jelölni kell az alkalmazott technikát. A transzamináz-aktivitások (GOT/AST, GPT/ALT) meghatározásakor kritikus a piridoxál-foszfát (B6-vitamin) jelenléte a reagensben. Ennek hiányában a mért értékek 15–30%-kal alacsonyabbak lehetnek. Ez téves diagnózishoz vezethet, különösen a májfibrosis becslésére szolgáló FIB4-pontszám számításakor. Ezért piridoxál-foszfátot tartalmazó reagensek alkalmazása javasolt a transzamináz-aktivitások mérésére. Az albumin mérésére a brómkrezolzöld helyett brómkrezolvörös reagens használata javasolt, mivel az előbbi májbetegségben és veseelégtelenségben pontatlan eredményeket ad. A módszerváltásokat a klinikusokkal egyeztetve kell végrehajtani, illetve oda kell figyelni arra is, hogy a vizsgálatok LOINC-kódja (egységes nevezéktanon alapuló kódrendszer) változhat. Orv Hetil. 2026; 167(6): 211–216. | Despite advances in modern medicine, classic laboratory parameters are still crucial pillars of clinical decision-making. The report focuses on four routinely measured analytes: serum creatinine levels, liver transaminase activities and al- bumin levels. In 2024, these accounted for more than 15% of laboratory determinations in Hungary. Laboratories measure serum creatinine levels using two methods: the Jaffé or the enzymatic method. Although both are suitable for estimating the glomerular filtration rate (GFR), the results may differ by 5–14% from each other. According to the professional opinion, both methods can be used, but they should be indicated on the report. The presence of pyridoxal phosphate (vitamin B6) in the reagent is critical for the determination of transaminase activities (GOT/ AST, GPT/ALT). In its absence, the measured values may be 15–30% lower, which may lead to misdiagnosis, espe- cially when calculating the FIB4 score for estimating the severity of liver fibrosis. Therefore, the use of reagents containing pyridoxal phosphate is recommended for measuring transaminase activities. In the case of albumin deter- mination, the use of bromocresol red reagent is recommended instead of bromocresol green, as the former gives inaccurate results in liver disease and renal failure. Method changes should be made in consultation with clinicians, and it should be noted that the LOINC codes (an international standard for parameter identification) for the tests may change. true true 2026 false false true false true false GOLD 2026-06-24 true https://doi.org/10.1556/650.2026.33490 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10 10 Q4 A false false false false 2026-05-10T08:35:55.744+0000 Klinikai Laboratóriumi Kutató Tanszék (DE / ÁOK / LMI); Orvosi Hetilap szerkesztősége (Kiadók / MTA KFB) 2 29 2 3 0 true Language 10001 /api/language/10001 Hungarian Magyar Hungarian true 1 true PersonAuthorship 133894970 /api/authorship/133894970 Vásárhelyi, Barna ✉ [Vásárhelyi, Barna (gyermekgyógyászat), author] 1 0.333 true false true Author 10003195 /api/author/10003195 Barna Vásárhelyi (gyermekgyógyászat) Vásárhelyi Barna true 10003195 true Vásárhelyi Barna true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 133894971 /api/authorship/133894971 Bereczky, Zsuzsanna [Bereczky, Zsuzsanna (véralvadás), author] Klinikai Laboratóriumi Kutató Tanszék (UD / DLM) 2 0.33333334 false false false Author 10022095 /api/author/10022095 Zsuzsanna Bereczky (véralvadás) Bereczky Zsuzsanna true 10022095 true Bereczky Zsuzsanna true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 133894972 /api/authorship/133894972 Miseta, Attila 3 0.33333334 false true false Miseta Attila true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true Institute 22368 /api/institute/22368 Editorial Office of the Orvosi Hetilap Kiadók / MTA KFB 0 false false true Orvosi Hetilap szerkesztősége Editorial Office of the Orvosi Hetilap true true PublicationIdentifier 31383472 /api/publicationidentifier/31383472 DOI: 10.1556/650.2026.33490 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true GOLD true IDENTICAL 10.1556/650.2026.33490 https://doi.org/10.1556/650.2026.33490 false true PublicationIdentifier 31383475 /api/publicationidentifier/31383475 REAL: 233573 SwordSource 36 /api/publicationsource/36 REAL PublicationSourceType 10007 /api/publicationsourcetype/10007 Repozitórium true true true REAL REAL https://real.mtak.hu/@@@ true true 36 true GREEN true 233573 https://real.mtak.hu/233573 false true PublicationIdentifier 31598920 /api/publicationidentifier/31598920 WoS: 001684269300001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001684269300001 https://www.webofscience.com/wos/woscc/full-record/001684269300001 false true PublicationIdentifier 32083870 /api/publicationidentifier/32083870 Scopus: 105029779356 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 105029779356 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-105029779356 false true PublicationIdentifier 31435873 /api/publicationidentifier/31435873 PubMed: 41655157 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 41655157 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=41655157&dopt=Abstract false true Classification 12125 /api/classification/12125 Basic medicine true true MtaRating 10487092 /api/mtarating/10487092 II. Committee on Psychology:A ORVOSI HETILAP 0030-6002 1788-6120 RatingType 10026 /api/ratingtype/10026 II. Committee on Psychology PsziTB Institute 14108 /api/institute/14108 Committee on Psychology HASSPHSII PsziTB [1901-] 0 false true false Pszichológiai Tudományos Bizottság Committee on Psychology true 14108 true true true A true true MtaRating 11507998 /api/mtarating/11507998 IX. Committee on Demography:A hazai ORVOSI HETILAP 0030-6002 1788-6120 RatingType 10011 /api/ratingtype/10011 IX. Committee on Demography DEM Institute 19060 /api/institute/19060 Committee on Demography HASSELIX DEM [1901-] 0 false true false Demográfiai Osztályközi Állandó Bizottság Committee on Demography true 19060 true true true A hazai false true SjrRating 11703762 /api/sjrrating/11703762 sjr:Q4 (2026) Scopus - Medicine (miscellaneous) ORVOSI HETILAP 0030-6002 1788-6120 1937 1.0 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2701 /api/classificationexternal/2701 Scopus - Medicine (miscellaneous) true 2701 true Q4 FROM_LAST_YEAR true true Reference 72251395 /api/reference/72251395 1. Németh Z, Takács I, Molnár B. Epigenetic changes of DNA and their research methods. [A DNS epigenetikai változásai és vizsgálati módszerei.] Orv Hetil. 2022; 163: 1334-1344. [Hungarian] https://doi.org/10.1556/650.2022.32508, DOI: 10.1556/650.2022.32508 1 10.1556/650.2022.32508 false true Reference 72251396 /api/reference/72251396 2. Galamb O, Sipos F, Molnár B, et al. Functional mRNA expression analysis and classification of colonic biopsy samples using overall cDNA microarray technique. [Vastagbél-biopszia funkcionális mRNS-expressziós vizsgálata és osztályozása általános cDNS microarray technikával.] Orv Hetil. 2008; 149: 219-233. [Hungarian] https://doi.org/10.1556/oh.2008.28056, DOI: 10.1556/oh.2008.28056 2 10.1556/oh.2008.28056 false true Reference 72251397 /api/reference/72251397 3. Hófer JH, Kárpáti JM, Bedics G, et al. The role of molecular pathology in the diagnosis, prognosis and management of childhood tumors. [A molekuláris patológia szerepe a gyermekkori tumorok diagnosztikájában, prognosztikájában és kezelésében.] Orv Hetil. 2025; 166: 1563-1573. [Hungarian] https://doi.org/10.1556/650.2025.33403, DOI: 10.1556/650.2025.33403 3 10.1556/650.2025.33403 false true Reference 72251398 /api/reference/72251398 4. Bánhegyi RJ, Rus PO, Taybani ZJ, et al. One perspective of the genetic correlations between obesity, type 2 diabetes and cancer. Possible role of FTO and TCF7L2 gene polymorphisms. [Az elhízás, a 2-es típusú diabetes és a daganatok közötti genetikai összefüggések egy perspektívája. Az FTO és TCF7L2 génpolimorfizmusok lehetséges szerepe.] Orv Hetil. 2024; 165: 499-509. [Hungarian] https://doi.org/10.1556/650.2024.33011, DOI: 10.1556/650.2024.33011 4 10.1556/650.2024.33011 false true Reference 72251399 /api/reference/72251399 5. Menyhárt O, Győrffy B, Szabó A. Diagnosis of genetic disorders in childhood with next-generation sequencing. [Gyermekkori genetikai rendellenességek diagnosztikája újgenerációs szekvenálással.] Orv Hetil. 2022; 163: 2027-2040. [Hungarian] https://doi.org/10.1556/650.2022.32688, DOI: 10.1556/650.2022.32688 5 10.1556/650.2022.32688 false true Reference 72251400 /api/reference/72251400 6. Tőke J, Tóth M. Diagnosis of adrenocortical carcinoma. [A mellékvesekéreg-carcinoma diagnosztikája.] Orv Hetil. 2024; 165: 123-131. [Hungarian] https://doi.org/10.1556/650.2024.32958, DOI: 10.1556/650.2024.32958 6 10.1556/650.2024.32958 false true Reference 72251401 /api/reference/72251401 7. Mihály Z, Győrffy B. Next generation sequencing technologies (NGST): development and applications. [Következő generációs szekvenálási technológiák kifejlődése és alkalmazásai.] Orv Hetil. 2011; 152: 55-62. [Hungarian] https://doi.org/10.1556/OH.2011.29007, DOI: 10.1556/OH.2011.29007 7 10.1556/OH.2011.29007 false true Reference 72251402 /api/reference/72251402 8. Levin A, Stevens PE, Bilous RW, et al. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013; 3: 1-150. 8 false true Reference 72251403 /api/reference/72251403 9. Haris Á, Mátyus J. Occurrence and prevention of iodinated contrast agent-induced kidney injury in light of the newest literature data: Time to change our clinical practice! [Radiojód kontrasztanyagok által okozott vesekárosodás és megelőzése az újabb irodalmi adatok tükrében. Változtassunk a gyakorlaton!] Orv Hetil. 2022; 163: 83-91. [Hungarian] https://doi.org/10.1556/650.2022.32364, DOI: 10.1556/650.2022.32364 9 10.1556/650.2022.32364 false true Reference 72251404 /api/reference/72251404 10. Kovács F, Sárváry E, Remport Á. Comparison of seven estimated glomerular filtration rate equations in kidney patients. [Hét, becsült glomerulusfiltrációs ráta egyenletének összehasonlítása veseelégtelenségben.] Orv Hetil. 2013; 154: 415-425. [Hungarian] https://doi.org/10.1556/OH.2013.29571, DOI: 10.1556/OH.2013.29571 10 10.1556/OH.2013.29571 false true Reference 72251405 /api/reference/72251405 11. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150: 604-612. Erratum: Ann Intern Med. 2011; 155: 408. https://doi.org/10.7326/0003-4819-150-9-200905050-00006, DOI: 10.7326/0003-4819-150-9-200905050-00006 11 10.7326/0003-4819-150-9-200905050-00006 false true Reference 72251406 /api/reference/72251406 12. Hermida FJ, Lorenzo MJ, Pérez A, et al. Comparison between ADVIA chemistry systems enzymatic creatinine_2 method and ADVIA chemistry systems creatinine method (kinetic Jaffe method) for determining creatinine. Scand J Clin Lab Invest. 2014; 74: 629-636. https://doi.org/10.3109/00365513.2014.928943, DOI: 10.3109/00365513.2014.928943 12 10.3109/00365513.2014.928943 false true Reference 72251407 /api/reference/72251407 13. Boss K, Stolpe S, Müller A, et al. Effect of serum creatinine difference between the Jaffe and enzymatic method on kidney disease detection and staging. Clin Kidney J. 2023; 16: 2147-2155. https://doi.org/10.1093/ckj/sfad178, DOI: 10.1093/ckj/sfad178 13 10.1093/ckj/sfad178 false true Reference 72251408 /api/reference/72251408 14. Fehér KE, Papp M. Evaluation of liver enzymes in clinical practice. [A májenzimeltérések értékelése a klinikai gyakorlatban.] Magy Belorv Arch. 2019; 72: 18-30. [Hungarian] 14 false true Reference 72251409 /api/reference/72251409 15. Pár A, Wittmann I, Pár G. Non-alcoholic fatty liver disease and type 2 diabetes mellitus. I. Pathogenesis. [A nem alkoholos zsírmájbetegség és a 2-es típusú cukorbetegség. I. Patogenezis.] Orv Hetil. 2022; 163: 815-825. [Hungarian] https://doi.org/10.1556/650.2022.32479, DOI: 10.1556/650.2022.32479 15 10.1556/650.2022.32479 false true Reference 72251410 /api/reference/72251410 16. Pár A. Chronic hepatitis C: virological and immunological features and therapeutic issues. [Krónikus C hepatitis: virológiai, immunológiai sajátosságok és a terápia kérdései.] Orv Hetil. 1997; 138: 1465-1476. [Hungarian] 16 false true Reference 72251411 /api/reference/72251411 17. Bajnok L. New evidence and recommendations in lipidology. [Újabb lipidológiai evidenciák és ajánlások.] Orv Hetil. 2018; 159: 1303-1309. [Hungarian] https://doi.org/10.1556/650.2018.31192, DOI: 10.1556/650.2018.31192 17 10.1556/650.2018.31192 false true Reference 72251412 /api/reference/72251412 18. Schumann G, Bonora R, Ceriotti F, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. Part 4. Clin Chem Lab Med. 2002; 40: 718-724., DOI: 10.1515/CCLM.2002.110 18 10.1515/CCLM.2002.110 false true Reference 72251413 /api/reference/72251413 19. Bergmeyer HU, Hørder M, Rej R. IFCC approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes. Part 2. J Clin Chem Clin Biochem. 1986; 24: 497-510. 19 false true Reference 72251414 /api/reference/72251414 20. Talli I, Marchioro L, Zaninotto M, et al. Measurement of AST and ALT with Pyridoxal-5′-Phosphate according to IFCC: a decades-long gap seems to be filled. Clin Chim Acta 2025; 569: 120158. https://doi.org/10.1016/j.cca.2025.120158, DOI: 10.1016/j.cca.2025.120158 20 10.1016/j.cca.2025.120158 false true Reference 72251415 /api/reference/72251415 21. Vanderlinde RE. Review of pyridoxal phosphate and the transaminases in liver disease. Ann Clin Lab Sci. 1986; 16: 79-93. 21 false true Reference 72251416 /api/reference/72251416 22. Evans C, MacKenzie F, Marrington R. Variation in liver function testing and the effect of pyridoxal-5-phosphate on ALT, AST and FIB-4 results. Ann Clin Biochem. 2024; 61: 459-468. https://doi.org/10.1177/00045632241269741, DOI: 10.1177/00045632241269741 22 10.1177/00045632241269741 false true Reference 72251417 /api/reference/72251417 23. Kjeldby IK, Fosnes GS, Ligaarden SC, et al. Vitamin B6 deficiency and diseases in elderly people: a study in nursing homes. BMC Geriatr. 2013; 13: 13. https://doi.org/10.1186/1471-2318-13-13, DOI: 10.1186/1471-2318-13-13 23 10.1186/1471-2318-13-13 false true Reference 72251418 /api/reference/72251418 24. Bailey AD, Fulgoni VL III, Shah N, et al. Nutrient intake adequacy from food and beverage intake of US children aged 1-6 years from NHANES 2001-2016. Nutrients 2021; 13: 827. https://doi.org/10.3390/nu13030827, DOI: 10.3390/nu13030827 24 10.3390/nu13030827 false true Reference 72251419 /api/reference/72251419 25. Ho CL, Quay TA, Devlin AM, et al. Prevalence and predictors of low vitamin B6 status in healthy young adult women in Metro Vancouver. Nutrients 2016; 8: 538. https://doi.org/10.3390/nu8090538, DOI: 10.3390/nu8090538 25 10.3390/nu8090538 false true Reference 72251420 /api/reference/72251420 26. European Association for the Study of Diabetes; European Association for the Study of Obesity. EASL-EASD-EASO clinical practice guidelines on the management of MASLD. J Hepatol. 2024; 81: 492-542. 26 false true Reference 72251421 /api/reference/72251421 27. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973; 60: 646-649. https://doi.org/10.1002/bjs.1800600817, DOI: 10.1002/bjs.1800600817 27 10.1002/bjs.1800600817 false true Reference 72251422 /api/reference/72251422 28. Kim WR, Mannalithara A, Heimbach JK, et al. MELD 3.0: the Model for End-Stage Liver Disease updated for the modern era. Gastroenterology 2021; 161: 1887-1895.e4. https://doi.org/10.1053/j.gastro.2021.08.050, DOI: 10.1053/j.gastro.2021.08.050 28 10.1053/j.gastro.2021.08.050 false true Reference 72251423 /api/reference/72251423 29. Kalantar-Zadeh K, Kopple JD, Block G, et al. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001; 38: 1251-1263. https://doi.org/10.1053/ajkd.2001.29222, DOI: 10.1053/ajkd.2001.29222 29 10.1053/ajkd.2001.29222 false true Reference 72251424 /api/reference/72251424 30. Lang J, Katz R, Ix JH, et al. Association of serum albumin levels with kidney function decline and incident chronic kidney disease in elders. Nephrol Dial Transplant. 2018; 33: 986-992. https://doi.org/10.1093/ndt/gfx229, DOI: 10.1093/ndt/gfx229 30 10.1093/ndt/gfx229 false true Reference 72251425 /api/reference/72251425 31. Paar M, Fengler VH, Rosenberg DJ, et al. Albumin in patients with liver disease shows an altered conformation. Commun Biol. 2021; 4: 731. https://doi.org/10.1038/s42003-021-02269-w, DOI: 10.1038/s42003-021-02269-w 31 10.1038/s42003-021-02269-w false true Reference 72251426 /api/reference/72251426 32. Donadio C, Tognotti D, D/onadio E. Albumin modification and fragmentation in renal disease. Clin Chim Acta 2012; 413: 391-395. https://doi.org/10.1016/j.cca.2011.11.009, DOI: 10.1016/j.cca.2011.11.009 32 10.1016/j.cca.2011.11.009 false true Reference 72251427 /api/reference/72251427 33. Watanabe A, Matsuzaki S, Moriwaki H, et al. Problems in serum albumin measurement and clinical significance of albumin microheterogeneity in cirrhotics. Nutrition 2004; 20: 351-357. https://doi.org/10.1016/j.nut.2003.12.006, DOI: 10.1016/j.nut.2003.12.006 33 10.1016/j.nut.2003.12.006 false true Reference 72251428 /api/reference/72251428 34. Delanghe S, Van Biesen W, Van de Velde N, et al. Binding of bromocresol green and bromocresol purple to albumin in hemodialysis patients. Clin Chem Lab Med. 2018; 56: 436-440. https://doi.org/10.1515/cclm-2017-0444, DOI: 10.1515/cclm-2017-0444 34 10.1515/cclm-2017-0444 false true Reference 72251429 /api/reference/72251429 35. Garcia Moreira V, Beridze Vaktangova N, Martinez Gago MD, et al. Overestimation of albumin measured by bromocresol green vs bromocresol purple method: influence of acute-phase globulins. Lab Med. 2018; 49: 355-361. https://doi.org/10.1093/labmed/lmy020, DOI: 10.1093/labmed/lmy020 35 10.1093/labmed/lmy020 false true Reference 72251430 /api/reference/72251430 36. Xu Y, Wang L, Wang J, et al. Serum globulins contribute to discrepancies observed between bromocresol green and bromocresol purple assays of serum albumin concentration. Br J Biomed Sci. 2011; 68: 120-125. https://doi.org/10.1080/09674845.2011.11730338, DOI: 10.1080/09674845.2011.11730338 36 10.1080/09674845.2011.11730338 false true Reference 72251431 /api/reference/72251431 37. Penickova S, Benyaich S, Ambar I, et al. Reliability of albumin bromocresol green colorimetric method and clinical impact. Scand J Clin Lab Invest. 2024; 84: 452-458. https://doi.org/10.1080/00365513.2024.2420311, DOI: 10.1080/00365513.2024.2420311 37 10.1080/00365513.2024.2420311 false true Reference 72251432 /api/reference/72251432 38. Van de Logt AE, Rijpma SR, Vink CH, et al. The bias between different albumin assays may affect clinical decision-making. Kidney Int. 2019; 95: 1514-1517. https://doi.org/10.1016/j.kint.2019.01.042, DOI: 10.1016/j.kint.2019.01.042 38 10.1016/j.kint.2019.01.042 false true /api/publication/36932110 Vásárhelyi Barna et al. Néhány gondolat a szérum-kreatininszint, -transzaminázaktivitás és -albuminszint meghatározások módszertanáról. (2026) ORVOSI HETILAP 0030-6002 1788-6120 167 6 211-216<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10003195"><a href="/gui2/?type=authors&mode=browse&sel=10003195" target="_blank">Vásárhelyi Barna ✉ (<span class="authorship-author-name">Vásárhelyi Barna</span> <span class="authorAux-mtmt"> gyermekgyógyászat</span>) </a> </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10022095"><a href="/gui2/?type=authors&mode=browse&sel=10022095" target="_blank">Bereczky Zsuzsanna (<span class="authorship-author-name">Bereczky Zsuzsanna</span> <span class="authorAux-mtmt"> véralvadás</span>) </a> </span> <span class="author-affil"><span title="University of Debrecen">UD</span>/<span title="Faculty of Medicine">Faculty of Medicine</span>/<span title="Department of Laboratory Medicine">DLM</span>/Klinikai Laboratóriumi Kutató Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Miseta Attila </span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;36932110" target="_blank">Néhány gondolat a szérum-kreatininszint, -transzaminázaktivitás és -albuminszint meghatározások módszertanáról</a></div> <div> <span class="journal-title">ORVOSI HETILAP</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/0030-6002">0030-6002</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1788-6120">1788-6120</a>)</span>: <span class="journal-volume">167</span> <span class="journal-issue">6</span> <span class="page"> pp 211-216 </span> <span class="year">(2026)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Language: Hungarian | </span> <span class="identifiers"> <span class="id identifier oa_GOLD" title=" Gold "> <a style="color:blue" title="10.1556/650.2026.33490" target="_blank" href="https://doi.org/10.1556/650.2026.33490"> DOI </a> </span> <span class="id identifier oa_GREEN" title=" Green "> <a style="color:black" title="233573" target="_blank" href="https://real.mtak.hu/233573"> REAL </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001684269300001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001684269300001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="105029779356" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-105029779356"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="41655157" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=41655157&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Journal subject: Scopus - Medicine (miscellaneous)&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q4</div> <div class="journal-subject">Committee on Psychology HASSPHSII PsziTB [1901-]&nbsp;&nbsp;&nbsp;A</div> <div class="journal-subject">Committee on Demography HASSELIX DEM [1901-]&nbsp;&nbsp;&nbsp;A hazai</div> </div></OnlyViewableByAuthor> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;36932110&sort=publishedYear,desc&sort=title"> Number of cited publications: 10 </a> </div> <div class="mtid"><span class="long-pub-mtid">Publication: 36932110</span> | <span class="status-data status-ADMIN_APPROVED"> Admin approved </span> Core Citing | <span class="type-subtype">Journal Article ( Survey paper ) </span> | <span class="pub-category">Scientific</span> | <span class="publication-sourceOfData">WOS TAGGED</span> </div> <div class="special-affiliations"> Special affiliation: Editorial Office of the Orvosi Hetilap </div> <div class="lastModified">Last Modified: 2026.06.24. 11:36 Márta Molnár-Taga (SE 4-es admin) </div> </div></div>